Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 3 subunit G (EIF3G) is a core component of the eukaryotic translation initiation factor 3 (eIF3) multiprotein complex, which is essential for the initiation of mRNA translation. EIF3G is an RNA-binding protein required for several distinct steps during the initiation of protein synthesis, including the assembly of the 43S pre-initiation complex (PIC) by associating with the 40S ribosomal subunit and facilitating the recruitment of other eIFs and methionyl-tRNA, the stimulation of mRNA binding and scanning for the translation start site, and recycling of ribosomes after translation termination[3]. EIF3G specifically regulates the translation of mRNAs with complex long and GC-rich 5' untranslated regions (5'UTRs), and plays specialized roles in tissue- or context-specific translation, such as regulating neuronal protein synthesis and activity, as shown in both *C. elegans* and human studies[1][2]. Dysregulation of EIF3G or the entire eIF3 complex has been linked to various human diseases, especially cancers and neurological disorders[1][3]. Targeting EIF3G would be extremely challenging due to its non-redundant, essential role in general protein synthesis and the likelihood of broad cellular toxicity. No drugs currently target EIF3G directly.
Not applicable (no direct drug actions; the protein is part of a translation complex; mechanisms would hypothetically include modulation of translation initiation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit G (EIF3G).